Advertisement

Oncologie

, Volume 13, Issue 10–11, pp 755–757 | Cite as

Le cancer du sein de la femme âgée (hors situation métastatique)

  • Étienne Brain
  • Élisabeth Carola
  • Claire Falandry
  • Gilles Freyer
  • Frédérique Retornaz
Veille Bibliographique / Literature Monitoring
  • 65 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Aapro M, Bernard-Marty C, Brain EG, et al. (2011) Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper. Ann Oncol 22(2): 257–267PubMedCrossRefGoogle Scholar
  2. 2.
    Barnadas A, Gil M, González S, et al. (2009) Exemestane as primary treatment of estrogen receptor-positive breast cancer in postmenopausal women: a phase II trial. Br J Cancer 100(3): 442–449. Epub 2009 Jan 20PubMedCrossRefGoogle Scholar
  3. 3.
    Bear HD (2010) Neoadjuvant chemotherapy for operable breast cancer: individualizing locoregional and systemic therapy. Surg Oncol Clin N Am 19(3): 607–626PubMedCrossRefGoogle Scholar
  4. 4.
    Brain EG, Mertens C, Girre V, et al. (2011) Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: a French Geriatric Oncology Group (GERICO) phase II multicentre trial. Crit Rev Oncol Hematol 80(1): 160–170PubMedCrossRefGoogle Scholar
  5. 5.
    Chia YH, Ellis MJ, Ma CX (2010) Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool. Br J Cancer 103(6): 759–764. Epub 2010 Aug 10PubMedCrossRefGoogle Scholar
  6. 6.
    Dixon JM, Renshaw L, Macaskill EJ, et al. (2009) Increase in response rate by prolonged treatment with neoadjuvant letrozole. Breast Cancer Res Treat 113(1): 145–151. Epub 2008 Feb 9PubMedCrossRefGoogle Scholar
  7. 7.
    Ellis MJ, Miller WR, Tao Y et al. (2009) Aromatase expression and out-comes in the P024 neoadjuvant endocrine therapy trial. Breast Cancer Res Treat 116(2): 371–378. Epub 2008 Oct 22PubMedCrossRefGoogle Scholar
  8. 8.
    Ellis MJ, Tao Y, Luo J, et al. (2008) Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics. J Natl Cancer Inst 100(19): 1380–1388. Epub 2008 Sep 23PubMedCrossRefGoogle Scholar
  9. 9.
    Galimberti V, Botteri E, Chifu C, et al. (2011) Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Res Treat DOI:10.1007/s10549-011-1486-2-Published on lineGoogle Scholar
  10. 10.
    Lee SJ, Lindquist K, Segal MR, et al. (2006) Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295(7): 801–808PubMedCrossRefGoogle Scholar
  11. 11.
    Luciani A, Ascione G, Bertuzzi C, et al. (2010) Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. JCO 28(12): 2046–2050CrossRefGoogle Scholar
  12. 12.
    Mello-Grand M, Singh V, Ghimenti C, et al. (2010) Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer. Breast 121(2): 399–411. Epub 2010 Apr 29Google Scholar
  13. 13.
    Miller WR (2009) Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer. J Steroid Biochem Mol Biol 118(4–5): 273–276PubMedGoogle Scholar
  14. 14.
    Molina-Garrido MJ, Guillen-Ponce C (2011) Comparison of two frailty screening tools in older women with early breast cancer. Crit Rev Oncol Hematol 79: 51–64PubMedCrossRefGoogle Scholar
  15. 15.
    Overcash JA, Beckstead J, Extermann M, Cobb S (2005) The abbreviated comprehensive geriatric assessment (aCGA): a retrospective analysis. Crit Rev Oncol Hematol 54: 129–136PubMedCrossRefGoogle Scholar
  16. 16.
    Seo JH, Kim YH, Kim JS (2009) Meta-analysis of preoperative aromatase inhibitor versus tamoxifen in postmenopausal woman with hormone receptor-positive breast cancer. Cancer Chemother Pharmacol 63(2): 261–266. Epub 2008 Mar 26PubMedCrossRefGoogle Scholar
  17. 17.
    Soubeyran P, Bellera C, Goyard J, et al. (2011) Validation of the G8 screening tool in geriatric oncology: the ONCODAGE project. J Clin Oncol 29 (suppl; abstr 9001)Google Scholar
  18. 18.
    Veronesi U, Marubini E, Mariani L, et al. (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12(7): 997–1003PubMedCrossRefGoogle Scholar
  19. 19.
    Viehl CT, Langer I, Guller U, et al. (2011) Prognostic impact and therapeutic implications of sentinel lymph node micrometastases in early-stage breast cancer patients. J Surg Oncol 103(6): 531–533PubMedCrossRefGoogle Scholar

Copyright information

© Springer Verlag France 2011

Authors and Affiliations

  • Étienne Brain
  • Élisabeth Carola
  • Claire Falandry
  • Gilles Freyer
  • Frédérique Retornaz

There are no affiliations available

Personalised recommendations